Clinical course of alopecia after COVID-19

Suzuki, T.; Kutsuna, Satoshi; Saito, Sho; Kawashima, Akira; Okuhama, Ayako; Kanda, Kohei; Sato, Lubna; Inada, Makoto; Akiyama, Yutaro; Ide, Satoshi; Nakamura, Keiji; Nakamoto, Takato; Yamamoto, Kei; Ishikane, Masahiro; Iwamoto, Noriko; Morioka, Shigefumi; Hayakawa, Kayoko; Ohmagari, Norio

doi:10.1016/j.ijid.2021.04.088

Cited by 6 publications

(8 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is observed 3-4 months after physical or psychological distress such as viral infection, emotional stress, severe injuries, surgeries, difficult labor, drugs usage, endocrine disorders, and malnutrition [ 9 ]. Even if acute COVID-19 was not severe, the mental stress associated with the infection could cause TE [ 10 ].…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, physicians need to reduce anxiety by explaining to patients their conditions, sharing medical information, and eliminating their psychophysical stress by managing various systemic complications. Unfortunately, there are only a few reports, such as our case, wherein the hair loss was recovered to the original state [ 10 ]. Thus, we hope that this report will help physicians in encouraging their patients with hair loss after COVID-19.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Recovery From Alopecia After COVID-19

Otsuka¹,

Nakano²,

Hagiya³

et al. 2022

Cureus

View full text Add to dashboard Cite

Herein, we report a remarkable case of post-coronavirus disease 2019 (COVID-19) diffuse alopecia that gradually improved and recovered, and the hair volume returned approximately to the pre-infection level, seven months after the patient's first diagnosis of COVID-19. Approximately 20% of patients with COVID-19 develop alopecia a few months after the acute infection phase. Telogen effluvium is the major type of COVID-19 sequela secondary to physical or psychological distress. It is reversible and is expected to improve without any treatment, and it can be addressed by explaining to the patients their conditions, sharing medical information, and eliminating psychophysical stress by managing systemic complications.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Recovery From Alopecia After COVID-19

Otsuka¹,

Nakano²,

Hagiya³

et al. 2022

Cureus

View full text Add to dashboard Cite

show abstract

“…Previous studies showed that dysosmia and dysgeusia occurred in around 10% of patients after COVID-19 [ 11 , 19 ], however, it could be much more patients. The underlying causes of these conditions have yet to be clarified, and treatment strategies have not yet been established [ 20 ].…”

Section: Discussionmentioning

confidence: 99%

Clinical Characteristics of Japanese Patients Who Visited a COVID-19 Aftercare Clinic for Post-Acute Sequelae of COVID-19/Long COVID

Otsuka¹,

Tokumasu²,

Nakano³

et al. 2021

Cureus

View full text Add to dashboard Cite

The long-term clinical course, prognosis, and optimal management of symptoms and conditions after the acute phase of coronavirus disease 2019 remain to be elucidated. The purpose of this study was to clarify the characteristics of patients referred to a COVID-19 aftercare (CAC) clinic established at a tertiary academic hospital in Japan. MethodsThis study was a descriptive case series study. All patients who visited the CAC clinic between February 15 and September 17 in 2021 were included. Patients' background, chief complaints, and clinical courses after the onset of COVID-19 were described. ResultsA total of 87 Japanese patients (median age, 40.0 years; interquartile range [IQR], 26.5-53.0 years; 52.9% women) were referred to the CAC clinic. The median interval between the onset of COVID-19 and the visit to the clinic was 79.0 (IQR, 52.5-112.0) days. Referral sources were hospitals (36 patients), clinics (47 patients), a local healthcare center (3 patients), and other (1 patient). The most common chief complaint was general fatigue (50.4%) followed by dysosmia (28.7%), dysgeusia (26.4%), hair loss (18.4%), headache (17.2%), dyspnea (16.1%), and dyssomnia (13.1%). Respiratory symptoms were common in the early stages of the disease but were less common as the chief complaints when visiting the clinic. On the other hand, neurological, psychiatric, and extremity symptoms were predominant one month after the onset of COVID-19. ConclusionsRegardless of the severity in the acute phase, patients visiting our CAC clinic suffered from a variety of symptoms. General physicians skilled in using a comprehensive approach would be optimal to see patients with such complex symptoms.

show abstract

“… 25 This condition is more prevalent in women and may be associated with the severity of COVID‐19; however the psychological stress per se could cause TE even in less severe SARS‐CoV‐2 cases. 26 Moreover, a great majority of the TE cases have coexisted with androgenic alopecia (AGA), which could be another clue for the presence of psychopathic triggers. 14 Even in the settings of a severe SARS‐CoV‐2 infection, hypothyroidism should be excluded as the underlying cause of hair loss.…”

Section: Introductionmentioning

confidence: 99%

“…TE almost always has a diffuse pattern and occurs a few months after a physical or emotional stress as a result of early follicular transition to the telogen phase 25 . This condition is more prevalent in women and may be associated with the severity of COVID‐19; however the psychological stress per se could cause TE even in less severe SARS‐CoV‐2 cases 26 . Moreover, a great majority of the TE cases have coexisted with androgenic alopecia (AGA), which could be another clue for the presence of psychopathic triggers 14 .…”

Section: Introductionmentioning

confidence: 99%

The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss

Aryanian

Balighi

Hatami

et al. 2022

Dermatologic Therapy

View full text Add to dashboard Cite

The prevalence of hair loss has increased during COVID‐19. In this study, we review the current literature on incidence and characteristics of various types of COVID‐19‐related and COVID‐19‐vaccine‐ related hair loss including telogen effluvium, alopecia areata, friction alopecia and anagen effluvium. Regarding most of them, the more severe the infection, the more profound and prolonged the course of alopecia. However, the most important issue is reassuring the patients of the non‐serious nature of this complication, since psychological support is the most important factor in the earlier resolution of the condition.

show abstract

Clinical course of alopecia after COVID-19

Cited by 6 publications

References 4 publications

Recovery From Alopecia After COVID-19

Recovery From Alopecia After COVID-19

Clinical Characteristics of Japanese Patients Who Visited a COVID-19 Aftercare Clinic for Post-Acute Sequelae of COVID-19/Long COVID

The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss

Contact Info

Product

Resources

About